WVXU: After decades of efforts, researchers hope they're closer to a functional cure for HIV
UC expert shares insights on the latest treatments
More than 40 years have passed since five patients in California developed symptoms of a mysterious disease. The virus that causes AIDS was identified a few years later, and a blood test for HIV became available in 1985.
In the 1980s and early 1990s, contracting HIV was practically a death sentence. Nothing seemed to stop the virus from attacking a patient’s immune system and progressing into AIDS. And while there are now treatments that can render the virus undetectable in a patient’s bloodstream, a cure for HIV has been elusive.
WVXU's Cincinnati Edition explored the history of AIDS and the latest on treatments, with one of the featured experts being Carl Fichtenbaum, MD, of the Division of Infectious Diseases at the UC College of Medicine.
Carl Fichtenbaum, MD, of the Division of Infectious Diseases at the UC College of Medicine/Photo/Joe Fuqua II/UC Marketing + Brand
"It was very scary times and it was very hard on patients and healthcare providers," Fichtenbaum said of the early days of HIV. "We didn't know very much, we weren't sure how it was transmitted in the early days. There was a lot of stigma attached to it, and we had few treatments. We weren't sure how to treat all the infections, we weren't sure how to prevent them, so there was a lot of fear."
Fichtenbaum said a lot of early patients with AIDS in the 1980s faced a lot of discrimination, including from some healthcare providers. He said that was when he decided he was going to make it his passion and his mission in life because he wanted to help people.
Fichtenbaum said 40-plus year into the fight against AIDS, a variety of medications have been developed but there is still more work to do to make them completely effective.
"Our medications, unfortunately, stop the virus when it is trying to reproduce itself, but not when the virus is sleeping," he said. "We also have medications that people can take every day or sometimes an injection even that can prevent HIV from being acquired by somebody. So we have ways of preventing it, and we haven't been able to spread these methods in ways that it needs to be spread. That's the human factor, the organizational factor, the inadequacy of our public health system to really address health prevention problems."
Listen to the entire story here.
Read more about Fichtenbaum's mission of social justice through medicine here.
Next Lives Here
The University of Cincinnati is classified as a Research 1 institution by the Carnegie Commission and is ranked in the National Science Foundation's Top-35 public research universities. UC's graduate students and faculty investigate problems and innovate solutions with real-world impact. Next Lives Here.
Related Stories
2021 University Recognition Ceremony honors student achievements
April 13, 2021
The University of Cincinnati recognizes students each year who have made significant service, leadership, and academic contributions to the UC community. These students exemplify the spirit of what it means to be a Bearcat.
UC Day of Giving a success
April 28, 2021
University of Cincinnati Day of Giving’s 24-hour challenge was a tremendous success this year, raising $2,219,197 with 3,232 gifts. The fourth annual UC Day of Giving raised its most money to date with alumni, donors, students, faculty and staff joining together to support UC and UC Health.
President picks exceptional talent
April 28, 2021
The University of Cincinnati 2021 Presidential Leadership Medal of Excellence Awards honor six undergraduate scholars for scholarship, leadership, character, service and the ideals of the university. Awardees are spotlighted for exceptional academics, creativity, community service and innovation.
Grad students earn president's highest honor
April 28, 2021
The University of Cincinnati 2021 Presidential Medal of Graduate Student Excellence Awards honor three graduate scholars for scholarship, leadership, character, service and the ideals of the university. Awardees are spotlighted for exceptional academics, creativity, community service and innovation.
GIVEHOPE and BSI Engineering Celebrate Ten Years of Driving Research
August 3, 2021
Years after two personal losses from pancreatic cancer, Cincinnati-based nonprofit GIVEHOPE and consulting firm BSI Engineering are celebrating a philanthropic partnership that has funded 13 pilot research projects at the University of Cincinnati Cancer Center.
Finding community and building a future
July 9, 2021
As a University of Cincinnati College of Medicine student, Sarah Appeadu, MD, ’21, remembers journaling on the “3 Cs” that got her through medical school: Community, community, community. Now, when she lists the people who supported her through four years of training—the last year in a global pandemic—it keeps growing: her family, her church, her classmates, and the college’s Office of Student Affairs and Office of Diversity, Equity and Inclusion. “I look back and it was such a crucial time to really be nurtured in that way,” she says. “I’m so thankful that I had those people. It shows being around the right people really mattered. That’s my same hope for residency even.”
New York Times: Flint Weighs Scope of Harm to Children Caused by Lead in Water
February 1, 2016
Kim Dietrich, a professor of environmental health at UC's College of Medicine, is quoted in this story on the medical problems that could develop among the thousands of young children exposed to lead-contaminated water in Flint, Mich.
Cancer-Causing Gene Found in Plasma May Help Predict Outcomes for Patients
February 18, 2016
Researchers at the University of Cincinnati have discovered that a human cancer-causing gene, called DEK, can be detected in the plasma of head and neck cancer patients.
UC Receives $1.9 Million to Study Pain
February 15, 2016
Jun-Ming Zhang, MD, of the UC College of Medicine, is the principal investigator of a $1.95 million grant to study the interacting roles of the sympathetic and sensory nervous and immune systems in back and neuropathic pain models.
MD Magazine: Generic Drug Equally Effective in Epilespy
February 22, 2016
Michael Privitera, MD, a professor of neurology at UC's College of Medicine and director of the Epilepsy Center at the UC Neuroscience Institute, is featured in this story about research he led that examined the efficacy of generic drug substitution for epilepsy.